Edward Freedman, J.D., serves as chief financial officer at Faze Medicines. Ed brings more than two decades of financial, legal and operational leadership expertise to his role, specializing in early-stage biotech companies. He also serves as founder and principal at his firm, Freedman Advisors, and chief operating officer at Pandion Therapeutics. Previously, Ed served as chief financial officer at KSQ Therapeutics, chief financial officer at Xtuit Pharmaceuticals, chief financial officer and general counsel at Oasys Water, vice president of operations and finance and general counsel at Ensemble Therapeutics, and general counsel at Flagship Ventures. Ed earned his JD from Boston College Law School and his BSBA in accounting from Boston University.